European Organisation For Research And Treatment Of Cancer - Eortc
Clinical trials sponsored by European Organisation For Research And Treatment Of Cancer - Eortc, explained in plain language.
-
Drug tested to keep aggressive lung cancer at bay
Disease control TerminatedThis study tested whether a drug called nintedanib could help control malignant pleural mesothelioma, a serious cancer of the lung lining, after patients completed initial chemotherapy. The trial compared nintedanib against a placebo (inactive pill) in patients whose cancer had n…
Phase: PHASE2 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Targeted therapy tested to fight rare brain cancer in young adults
Disease control TerminatedThis trial tested a personalized treatment approach for young adults with medulloblastoma, a rare and aggressive brain cancer. It aimed to see if using a targeted drug called sonidegib, along with reduced radiation, could work better with fewer side effects than standard treatmen…
Phase: PHASE2 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC